# Developmental Nicotine Exposure Induces Intergenerational Transmission of an Ensemble of Neurodevelopmental Disorder-Related Translatomic Perturbations in DRD1-Expressing Striatal Cells of Adolescent Male Mice

**Authors:** Jordan M. Buck, Marko Melnick, Jerry A. Stitzel

PMC · DOI: 10.3390/genes17020128 · Genes · 2026-01-25

## TL;DR

Exposure to nicotine during development can cause lasting gene expression changes in brain cells of mice, increasing the risk of neurodevelopmental disorders across generations.

## Contribution

This study identifies specific gene expression patterns in dopamine receptor D1-expressing striatal cells linked to neurodevelopmental disorders in multiple generations of mice.

## Key findings

- Dopamine receptor D1-expressing striatal cells show altered gene expression in first- and second-generation offspring of nicotine-exposed mothers.
- These gene expression changes are associated with neurodevelopmental disorders and shared neurobiological and epigenomic traits.
- The findings suggest nicotine-induced epigenomic dysregulation may drive intergenerational neurodevelopmental deficits.

## Abstract

Background/Objectives: Coupled with the already-problematic background rates of traditional cigarette consumption during pregnancy, the surging epidemic of electronic cigarette usage among pregnant women redoubles the importance of understanding the impacts of nicotine exposure during critical periods of development. To date, a burgeoning body of human epidemiological and animal model research indicates that not only the children but also the grandchildren of maternal smokers are at higher risk for neurodevelopmental disorders such as ADHD, autism, and schizophrenia and are predisposed to neurodevelopmental abnormalities which transcend these diagnoses. However, the roles of discrete cellular sub-populations in these and other intergenerational consequences of smoking during pregnancy remain indeterminate. Methods: Toward the resolution of this void in the literature, the present study characterized alterations in the gene expression profiles of dopamine receptor D1-expressing striatal cells from the first- and second-generation male progeny of female mice that were continuously exposed to nicotine beginning prior to conception, continuing throughout pregnancy, and concluding upon weaning of offspring. Results: Dopamine receptor D1-expressing striatal cells from our mouse models of the children and grandchildren of maternal smokers exhibit differential expression patterns for a multitude of genes that are (1) individually associated with neurodevelopmental disorders, (2) collectively overrepresented in gene set annotations related to brain, behavioral, neurobiological, and epigenomic phenotypes shared among neurodevelopmental disorders, and (3) orthologous to human genes that exhibit differential DNA methylation signatures in the newborns of maternal smokers. Conclusions: Together with our and others’ previous findings, the results of this study support the emerging theory that, by inducing extensive alterations in gene expression that in turn elicit cascading neurobiological changes which ultimately confer widespread neurobehavioral abnormalities, nicotine-induced epigenomic dysregulation may be a primary driver of neurodevelopmental deficits and disorders in the children and grandchildren of maternal smokers.

## Linked entities

- **Chemicals:** nicotine (PubChem CID 942)
- **Diseases:** ADHD (MONDO:0007743), autism (MONDO:0005260), schizophrenia (MONDO:0005090)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Slc6a3 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) [NCBI Gene 13162] {aka DAT, Dat1}, Gpbar1 (G protein-coupled bile acid receptor 1) [NCBI Gene 227289] {aka BG37, GPCR, GPR131, M-BAR, TGR5}, Phf24 (PHD finger protein 24) [NCBI Gene 230085] {aka GINIP}, Fkbp5 (FK506 binding protein 5) [NCBI Gene 14229] {aka D17Ertd592e, Dit1, FKBP-5, FKBP51}, Hsp90aa1 (heat shock protein 90, alpha (cytosolic), class A member 1) [NCBI Gene 15519] {aka 86kDa, 89kDa, Hsp86-1, Hsp89, Hsp90, Hspca}, Cbln3 (cerebellin 3 precursor protein) [NCBI Gene 56410], Dtnbp1 (dystrobrevin binding protein 1) [NCBI Gene 94245] {aka 5430437B18Rik, Bloc1s8, dysbindin, sdy}, Gast (gastrin) [NCBI Gene 14459] {aka GAS}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, Polr3b (polymerase (RNA) III (DNA directed) polypeptide B) [NCBI Gene 70428] {aka 2700078H01Rik, A330032P03Rik, C128, RPC2}, Nme7 (NME/NM23 family member 7) [NCBI Gene 171567] {aka D530024H21Rik, NDK7, Nm23-M7, Nm23-r7, nm23-H7}, Slc1a2 (solute carrier family 1 (glial high affinity glutamate transporter), member 2) [NCBI Gene 20511] {aka 1700091C19Rik, 2900019G14Rik, Eaat2, GLT-1, GLT1, MGLT1}, Acp5 (acid phosphatase 5, tartrate resistant) [NCBI Gene 11433] {aka TRACP, TRAP}, Aldh1a1 (aldehyde dehydrogenase family 1, subfamily A1) [NCBI Gene 11668] {aka ALDH-E1, ALHDII, Ahd-2, Ahd2, Aldh1, Aldh1a2}, Hdac2 (histone deacetylase 2) [NCBI Gene 15182] {aka D10Wsu179e, YAF1, Yy1bp, mRPD3}, Adh1 (alcohol dehydrogenase 1 (class I)) [NCBI Gene 11522] {aka ADH-A2, ADH-AA, Adh-1, Adh-1-t, Adh-1e, Adh-1t}, Cyp21a1 (cytochrome P450, family 21, subfamily a, polypeptide 1) [NCBI Gene 13079] {aka 21-OH, 21OH, 21OHA, 21OHB, CYP21OH-A, Cyp21}, Zkscan16 (zinc finger with KRAB and SCAN domains 16) [NCBI Gene 100041581] {aka XM_143800, Zfp483}, Golt1a (golgi transport 1A) [NCBI Gene 68338] {aka 0610012C01Rik, Kiss1, metastatin}, Npsr1 (neuropeptide S receptor 1) [NCBI Gene 319239] {aka 9330128H10Rik, GPRA, Gpr154, MVTR, PGR14, VRR1}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Gpr34 (G protein-coupled receptor 34) [NCBI Gene 23890] {aka Lypsr1}, Gjc2 (gap junction protein, gamma 2) [NCBI Gene 118454] {aka B230382L12Rik, Cx47, Cxno, Gja12}, Plg (plasminogen) [NCBI Gene 18815] {aka Pg}, Hspb1 (heat shock protein family B (small) member 1) [NCBI Gene 15507] {aka 27kDa, Hsp25}, Pde4a (phosphodiesterase 4A, cAMP specific) [NCBI Gene 18577] {aka D9Ertd60e, Dpde2}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Rmdn3 (regulator of microtubule dynamics 3) [NCBI Gene 67809] {aka 1200015F23Rik, Fam82a2, Ptpip51, RMD-3, Rmd3}, Cpne8 (copine VIII) [NCBI Gene 66871] {aka 1200003E11Rik, 1500031E20Rik}, Asb3 (ankyrin repeat and SOCS box-containing 3) [NCBI Gene 65257] {aka 2400011J03Rik, Asb-3}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Usp18 (ubiquitin specific peptidase 18) [NCBI Gene 24110] {aka 1110058H21Rik, UBP43, Ubp15}, Erbb2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 13866] {aka Erbb-2, HER-2, HER2, Neu, c-erbB2, c-neu}, Crhr1 (corticotropin releasing hormone receptor 1) [NCBI Gene 12921] {aka CRF-R1alpha, CRF1R, CRFR1, Crhr}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Crh (corticotropin releasing hormone) [NCBI Gene 12918] {aka CRF, Gm1347}, Gpr55 (G protein-coupled receptor 55) [NCBI Gene 227326] {aka CTFL, Gm218, Lpir1}, Ints7 (integrator complex subunit 7) [NCBI Gene 77065] {aka 5930412E23Rik, int7}, Plch2 (phospholipase C, eta 2) [NCBI Gene 269615] {aka A930027K05Rik, PLCeta2, Plc-eta2, Plcl4}, Cabin1 (calcineurin binding protein 1) [NCBI Gene 104248] {aka A330070M20Rik, Cain, Ppp3in}, Ccl21b (C-C motif chemokine ligand 21B (leucine)) [NCBI Gene 100042493] {aka 6CKBAC1, 6Ckine, CKb9, SLC, Scya21, Scya21a}, Drd1 (dopamine receptor D1) [NCBI Gene 13488] {aka C030036C15Rik, Drd-1, Drd1a, Gpcr15}, Pnpt1 (polyribonucleotide nucleotidyltransferase 1) [NCBI Gene 71701] {aka 1200003F12Rik, Old35, PNPase, Pnptl1}, Dnmt3a (DNA methyltransferase 3A) [NCBI Gene 13435] {aka MmuIIIA}, Tcf23 (transcription factor 23) [NCBI Gene 69852] {aka 2010002O16Rik, Out, bHLHa24}, Ift25 (intraflagellar transport 25) [NCBI Gene 72938] {aka 2900042B11Rik, Hspb11, PP25}, Tmem44 (transmembrane protein 44) [NCBI Gene 224090] {aka 1700007N03Rik, 9330161C17Rik, B230220N21}, DRD1 (dopamine receptor D1) [NCBI Gene 1812] {aka D1R, DADR, DRD1A}, Elof1 (ELF1 homolog, elongation factor 1) [NCBI Gene 66126] {aka 1110011K10Rik}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, Hmgn3 (high mobility group nucleosomal binding domain 3) [NCBI Gene 94353] {aka 1110002A15Rik, 6330514M13Rik, TRIP7}, Dnah6 (dynein, axonemal, heavy chain 6) [NCBI Gene 330355] {aka 9830168K20, A730004I20Rik, Dnahc6, mKIAA1697, mdhc6}, Ddit4 (DNA-damage-inducible transcript 4) [NCBI Gene 74747] {aka 5830413E08Rik, REDD1, Rtp801, dig2}, Polr2f (polymerase (RNA) II (DNA directed) polypeptide F) [NCBI Gene 69833] {aka 1810060D16Rik, RPB6}, Gdf10 (growth differentiation factor 10) [NCBI Gene 14560] {aka Bmp3b}, Pbx2 (pre B cell leukemia homeobox 2) [NCBI Gene 18515] {aka G17}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Lrrk2 (leucine-rich repeat kinase 2) [NCBI Gene 66725] {aka 4921513O20Rik, 9330188B09Rik, D630001M17Rik, Gm927, cI-46}, Zfp982 (zinc finger protein 982) [NCBI Gene 195531] {aka Gm13152}
- **Diseases:** neuronal activity (MESH:D009410), impaired prepulse inhibition (MESH:C565433), stillbirth (MESH:D050497), miscarriage (MESH:D000022), impulsivity (MESH:D007174), neonatal morbidities (MESH:D007232), DMGs (MESH:D012734), neurotransmitter system (MESH:D015619), prematurity (MESH:C536271), NDDs (MESH:D002658), HPA axis dysregulation (MESH:C566610), birth defects (MESH:D000014), neurodevelopmental harms (MESH:D008607), brain (MESH:D001927), sudden infant death syndrome (MESH:D013398), neurotransmitter system dysfunction (MESH:D007154), ADHD (MESH:D001289), neurodevelopmental anomalies (MESH:C567101), GMS (MESH:D015208), neurobehavioral abnormalities (MESH:D019954), impaired learning, memory (MESH:D007859), neurodevelopmental deficits (MESH:D009461), metabolic abnormalities (MESH:D008659), hyperactivity (MESH:D006948), DNE (MESH:D014029), injury to (MESH:D014947), neurodegeneration (MESH:D019636), inflammatory (MESH:D007249), neurotrophic dysfunction (MESH:D009133), neurotranslatomic anomaly (MESH:D000013), mitochondrial dysfunction (MESH:D028361), behavioral anomalies (MESH:D001523), substance abuse (MESH:D019966), Huntington's disease (MESH:D006816), Down syndrome (MESH:D004314), Cancer (MESH:D009369), autism (MESH:D001321), sleep disruptions (MESH:D019958), developmental encephalopathy (MESH:C567924), neurodevelopmental abnormalities (MESH:D063647), neuroinflammation (MESH:D000090862), schizophrenia (MESH:D012559), anxiety (MESH:D001007)
- **Chemicals:** ATP (MESH:D000255), citric acid (MESH:D019343), glutathione (MESH:D005978), agarose (MESH:D012685), KCl (MESH:D011189), spermidine (MESH:D013095), cycloheximide (MESH:D003513), GC (MESH:C057580), polyA (MESH:D011061), 1,2-Diheptanoyl-sn-Glycero-3-Phosphocholine (-), HEPES (MESH:D006531), methylphenidate (MESH:D008774), TCA (MESH:D014238), NIC (MESH:D009538), Water (MESH:D014867), S-adenosylmethionine (MESH:D012436), acetylcholine (MESH:D000109), GABA (MESH:D005680), dithiothreitol (MESH:D004229), glutamate (MESH:D018698), MgCl2 (MESH:D015636), pyruvate (MESH:D019289), oxygen (MESH:D010100), NP-40 (MESH:C010615), saccharin (MESH:D012439), prostaglandin (MESH:D011453), DA (MESH:C025953), DHPC (MESH:C052298), corticosterone (MESH:D003345), pentose phosphate (MESH:D010428)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** rs16969968, D397N, D379N, D397
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940388/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940388/full.md

## References

197 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940388/full.md

---
Source: https://tomesphere.com/paper/PMC12940388